Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Emergent BioSolutions›
Website
AddedMar 19, 2024
UpdatedJul 3, 2026
Emergent BioSolutions

Emergent BioSolutions

Public

American biopharmaceutical company developing vaccines and therapeutics in Gaithersburg, MD.

HQ
Gaithersburg, MD, US
Founded
1998
Loading
Overview
Compare
Fundraising
Employees
Website

Emergent BioSolutions - Website

An index of every page on emergentbiosolutions.com, by section.

30 pages across 7 sections · Updated Jul 15, 2026·

Homepage

Emergent BioSolutions's front door: current positioning and top-line messaging.

emergentbiosolutions.com
  • Homepageoff-site

TeamJennifer Fox

Leadership and the people behind Emergent BioSolutions, as the company presents them.

  • Jennifer Fox/team/jennifer-fox
  • Haywood Miller/team/haywood-miller
  • Joseph Papa Bod/team/joseph-papa-bod
  • Joseph Papa/team/joseph-papa
  • Bill Hartzel/team/bill-hartzel
  • Paul Williams/team/paul-williams

PressEmergent Biosolutions to Participate in Investor Conferences 4

Official announcements and statements: 6 pages in Emergent BioSolutions's own words.

  • Emergent Biosolutions to Participate in Investor Conferences 4off-site
  • Emergent Biosolutions to Host 2019 Analyst and Investor Dayoff-site
  • News Release Details Emergent Biosolutions Host 2019 Analyst Investor Dayoff-site
  • News Release Details Emergent Biosolutions Reports Financial Results Third Quarter 7off-site
  • News Release Details Emergent Biosolutions Announces Growth Strategy and 2024 Goalsoff-site
  • News Release Details Emergent Biosolutions Board Members Dr Sue Bailey and Dr Kathrynoff-site

PrivacyPrivacy Policy

How Emergent BioSolutions collects, uses, and safeguards data: the canonical policy set.

  • Privacy Policy/privacy-policy
  • Privacy Policyoff-site/privacy-policy

Careers

Open roles and how Emergent BioSolutions recruits: 6 careers pages straight from the source.

emergentbiosolutions.com/careers
  • Locations/careers/locations
  • Life at Emergent/careers/life-at-emergent
  • Careersoff-site/careers
  • Locationsoff-site/careers/locations
  • Life at Emergentoff-site/careers/life-at-emergent

BlogOur Commitments Combat Covid 19

Product updates, deep-dives, and company thinking: Emergent BioSolutions's 6-post archive.

  • Our Commitments Combat Covid 19
  • Emergent Biosolutions CEO Robert G Kramer Appointed Manufacturers Association Board
  • Story Conversation Sean Kirk
  • Bio International 2019 with Sean Kirk
  • Emergent Biosolutions Vice President Thom Duddy Joins Dr Phil Show
  • Emergent Biosolutions New President and CEO Bob Kramer Joins Rich Bendis Biotalk

ContactContact Us

Sales, support, and partnership channels for reaching Emergent BioSolutions directly.

  • Contact Us/contact-us
  • Contact Usoff-site/contact-us